BACKGROUND AND OBJECTIVE: The aim of the present study was to compare the risk stratification obtained with the Framingham function, recommended by the National Cholesterol Education Program (ATP-III), and the risk charts of the Systematic Coronary Risk Evaluation (SCORE) program, in a cohort of subjects between 20 and 75 years (mean 59 years, 70% females) with metabolic syndrome. SUBJECTS AND METHOD: Participants were classified as low, moderate, or high risk by ATP-III and by SCORE of risk at 10 years, respectively. RESULTS: 8.3% of males and 7.4% of women from our study were classified as high risk in 10 years time by Framingham-DORICA. Regarding SCORE program 50% men and 29.6% of women were considered to have high coronary risk. CONCLUSIONS: Risk estimation with SCORE and Framingham function shows significant gender and quantitative differences. There is no concordance between Framingham and SCORE function to estimate cardiovascular risk on subjects included on the high-risk group.
BACKGROUND AND OBJECTIVE: The aim of the present study was to compare the risk stratification obtained with the Framingham function, recommended by the National Cholesterol Education Program (ATP-III), and the risk charts of the Systematic Coronary Risk Evaluation (SCORE) program, in a cohort of subjects between 20 and 75 years (mean 59 years, 70% females) with metabolic syndrome. SUBJECTS AND METHOD:Participants were classified as low, moderate, or high risk by ATP-III and by SCORE of risk at 10 years, respectively. RESULTS: 8.3% of males and 7.4% of women from our study were classified as high risk in 10 years time by Framingham-DORICA. Regarding SCORE program 50% men and 29.6% of women were considered to have high coronary risk. CONCLUSIONS: Risk estimation with SCORE and Framingham function shows significant gender and quantitative differences. There is no concordance between Framingham and SCORE function to estimate cardiovascular risk on subjects included on the high-risk group.
Authors: F Villar Alvarez; A Maiques Galán; C Brotons Cuixart; J Torcal Laguna; R Ortega Sánchez-Pinilla; J Vilaseca Canals; D Forés García; J R Banegas Banegas; J M Lobos Bejarano; D Orozco Beltrán; V F Gil Guillén; C Llor Vila; A Lorenzo Piqueres; J Navarro Pérez Journal: Aten Primaria Date: 2003-12 Impact factor: 1.137
Authors: Gonzalo Ruiz-Villaverde; Martín López de la Torre-Casares; Daniel Sánchez-Cano; Carmen Villaverde-Gutiérrez Journal: Med Clin (Barc) Date: 2006-09-02 Impact factor: 1.725
Authors: José M Mostaza; Ignacio Vicente; Manuel Taboada; Fernando Laguna; Ana Echániz; Francisca García-Iglesias; Carlos Lahoz Journal: Med Clin (Barc) Date: 2005-04-09 Impact factor: 1.725
Authors: R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham Journal: Eur Heart J Date: 2003-06 Impact factor: 29.983